Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice (ULIS III)

Ipsen

Status: Completed

Conditions: Upper Limb Spasticity

Study type: Observational

Funder types: Industry

Identifiers

NCT02454803

Y-79-52120-206

Details and patient eligibility

About

The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the extent to which these are achieved in different individuals.

Enrollment: 1,004 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients with ULS, in whom a decision has already been made to inject botulinum toxin A (BoNT A).
• Patient has provided written informed consent for collection of the data.

Exclusion criteria

• Participation in any interventional clinical study of ULS within the 12 weeks prior to the inclusion visit (Visit 1).
• Patient has already been included in the current study, but was subsequently withdrawn.